Abbott Laboratories ABT

101.29 0.22 0.22% as of 25 Sep
Market cap
$174.8B
P/E
32.8×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
41.99 226.12 54.38 42.17 43.80 35.72 28.03 33.70 14.79 33.68
P/S ratio
2.77 3.73 4.16 4.81 5.61 5.80 4.40 4.77 4.69 4.92
P/FCF ratio
27.70 23.07 25.92 34.14 33.91 28.89 24.61 37.78 30.99 29.50
P/Operating CF
49.30 62.37 72.04 63.56 51.11 81.45 82.59 62.92 68.62 65.80
P/B ratio
2.78 3.29 4.14 4.91 5.88 6.93 5.21 4.92 4.11 4.13
Price to Tangible BV
6.79 0.00 0.00 0.00 0.00 4,626.18 52.60 30.18 10.85 9.40
EV/Sales
2.86 4.40 4.66 5.25 5.94 5.98 4.55 4.95 4.84 5.01
EV/EBITDA
13.11 21.90 20.47 22.18 23.67 21.53 17.09 20.42 20.21 19.89
EV/Operating CF
18.60 21.62 22.61 27.28 26.01 24.46 20.74 27.34 23.72 23.22
EV/FCF
28.62 27.15 29.03 37.21 35.90 29.79 25.46 39.24 31.96 30.04
Quick Ratio
3.31 1.67 1.03 0.88 1.14 1.28 1.06 1.00 1.05 1.02
Current Ratio
4.02 2.26 1.62 1.44 1.72 1.85 1.63 1.64 1.67 1.58
Net Debt/EBITDA
0.42 3.29 2.20 1.83 1.31 0.65 0.57 0.76 0.61 0.36
Debt/Assets
39.27% 36.35% 28.83% 26.42% 25.55% 24.00% 22.53% 20.05% 17.35% 14.91%
Debt/Equity
1.00 0.89 0.63 0.57 0.56 0.50 0.45 0.38 0.29 0.25
Asset Turnover
0.44 0.42 0.43 0.47 0.49 0.58 0.58 0.54 0.54 0.53
Operating CF/Net income
2.29 11.68 2.66 1.66 1.76 1.49 1.38 1.27 0.64 1.47
Capex/Depreciation
(0.74) (0.29) (0.42) (0.54) (0.65) (0.53) (0.54) (0.68) (0.69) (0.70)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
6.66% 1.84% 7.66% 11.89% 13.98% 20.49% 19.01% 15.11% 30.91% 12.96%
ROA
2.98% 0.74% 3.30% 5.46% 6.40% 9.57% 9.27% 7.75% 17.33% 7.76%
ROIC
8.36% 1.99% 4.96% 6.28% 7.54% 12.02% 12.01% 8.76% 7.89% 8.87%
Return on Tangible Assets
5.42% 2.53% 17.96% 28.71% 25.59% 35.19% 36.69% 30.15% 66.49% 30.61%
Average Days of Receivables
56.85 69.95 61.86 62.07 67.65 54.97 51.99 59.74 60.25 65.29
Research and Development Expense of Revenue
6.94% 8.25% 7.52% 7.65% 6.99% 6.37% 6.62% 6.83% 6.78% 6.64%
Selling, General and Administrative Expense of Revenue
32.30% 33.52% 31.87% 30.61% 28.02% 26.29% 25.77% 27.30% 27.88% 27.82%
Intangible Assets out of Total Assets
0.23 0.60 0.63 0.59 0.53 0.48 0.45 0.44 0.37 0.34
Share Based Compensation of Revenue
1.49% 1.48% 1.56% 1.63% 1.58% 1.49% 1.57% 1.61% 1.60% 1.50%
Graham Net Nets
(0.09) (0.24) (0.17) (0.14) (0.10) (0.06) (0.06) (0.06) (0.05) (0.04)
Graham Number
17.13 10.23 22.87 28.65 32.36 42.42 43.04 40.46 68.84 50.37
Earnings Yield
2.38% 0.44% 1.84% 2.37% 2.28% 2.80% 3.57% 2.97% 6.76% 2.97%
Free Cash Flow Yield
3.61% 4.34% 3.86% 2.93% 2.95% 3.46% 4.06% 2.65% 3.23% 3.39%
Revenue per Share
14.12 15.74 17.39 18.05 19.52 24.27 24.90 23.05 24.11 25.46
Operating CF per Share
2.17 3.20 3.58 3.47 4.46 5.93 5.47 4.17 4.92 5.49
Capex per Share
(0.76) (0.65) (0.79) (0.93) (1.23) (1.06) (1.01) (1.27) (1.27) (1.25)
Free Cash Flow per Share
1.41 2.55 2.79 2.54 3.23 4.87 4.45 2.91 3.65 4.25
Cash per Share
12.71 5.52 2.32 2.34 4.03 5.77 5.80 4.18 4.58 5.13
Shareholders Equity per Share
14.03 17.87 17.48 17.70 18.61 20.30 21.05 22.31 27.53 30.31
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
14.03 17.87 17.48 17.70 18.61 20.30 21.05 22.31 27.53 30.31
Free Cash Flow
2,082.00 4,435.00 4,906.00 4,498.00 5,724.00 8,648.00 7,804.00 5,059.00 6,351.00 7,395.00
Working Capital
20,116.00 11,235.00 5,620.00 4,804.00 8,534.00 11,134.00 9,735.00 8,829.00 9,499.00 9,500.00
Capital Expenditures
(1,121.00) (1,135.00) (1,394.00) (1,638.00) (2,177.00) (1,885.00) (1,777.00) (2,202.00) (2,207.00) (2,171.00)
Net Current Asset Value
(5,173.00) (25,005.00) (21,819.00) (20,919.00) (19,104.00) (14,933.00) (12,309.00) (11,717.00) (9,857.00) (7,946.00)
EV/EBIT
19.69 76.98 39.02 36.93 38.36 30.58 23.76 30.65 29.74 27.58
Capex to Sales
0.05 0.04 0.05 0.05 0.06 0.04 0.04 0.05 0.05 0.05
Net Profit Margin
6.71% 1.74% 7.74% 11.56% 12.99% 16.42% 15.88% 14.27% 31.95% 14.72%
Price to Operating Income
19.06 65.41 34.84 33.89 36.24 29.65 22.97 29.51 28.84 27.09
Other line items
Depreciation/Fixed assets
0.27 0.52 0.44 0.38 0.37 0.39 0.36 0.32 0.30 0.26
Cash ROIC
(4.16%) (2.98%) (2.33%) (3.56%) (1.92%) 2.45% 0.66% (4.76%) (3.00%) (3.01%)
Accounts Receivable Turnover
6.26 6.45 5.86 6.02 5.85 6.68 6.87 6.28 6.22 5.97
Accounts Payable Turnover
8.05 6.93 4.73 4.25 4.17 4.44 4.25 4.04 4.41 4.58
Inventory Turnover
3.61 4.11 3.44 3.26 3.22 3.65 3.38 2.82 2.93 3.05
Average Days of Payables
47.28 70.65 85.46 89.71 96.00 86.80 87.85 87.21 81.85 80.11
Days of Inventory on Hand
97.69 105.92 109.05 119.06 121.93 101.54 117.71 133.41 120.86 122.58
Average Receivables
3,333.00 4,248.50 5,215.50 5,303.50 5,919.50 6,450.50 6,352.50 6,391.50 6,745.00 7,427.00
Average Payables
1,129.50 1,790.00 2,688.50 3,113.50 3,599.00 4,177.00 4,507.50 4,451.00 4,245.00 4,217.50
Average Inventory
2,516.50 3,017.50 3,698.50 4,056.00 4,664.00 5,084.50 5,665.00 6,371.50 6,382.00 6,341.00
Average Assets
46,956.50 64,458.00 71,711.50 67,530.00 70,217.50 73,872.00 74,817.00 73,826.00 77,314.00 84,063.50
Average Common Equity
21,021.50 25,907.50 30,910.00 31,011.50 32,152.00 34,513.50 36,464.50 37,866.00 43,364.00 50,336.00

Fold the line items

Columns are period end dates